Treating post-stroke plantar flexor spasticity does not improve spatiotemporal gait parameters: Why another negative RCT?
- PMID: 37271021
- DOI: 10.1016/j.rehab.2023.101748
Treating post-stroke plantar flexor spasticity does not improve spatiotemporal gait parameters: Why another negative RCT?
Keywords: Botulinum toxin; Gait; Hemiparetic; Placebo; Spatiotemporal gait parameters; Stroke.
Conflict of interest statement
Conflicts of interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Jean Michel VITON reports financial support was provided by French governement ministry of health (PHRC). Jean Michel Viton reports a relationship with Allergan France and Merz Pharma that includes: travel reimbursement. Maëva Cotinat reports a relationship with Merz Pahrma and Allergan France that includes: travel reimbursement. Laurent Bensoussan reports a relationship with Allergan France that includes: travel reimbursement. Frederic PELLAS reports a relationship with Merz Pharma that includes: paid expert testimony, speaking and lecture fees, and travel reimbursement.
Publication types
LinkOut - more resources
Full Text Sources
